G Medical Innovations IPO Presentation Deck

Forward-Looking Statements All statements in this presentation, other than those relating to historical facts, are "forward-looking statements." Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and similar expressions or variations of such words are intended to identify forward-looking statements. For example, G Medical Innovations Holdings Ltd. (the "Company") is using forward-looking statements when it discusses its plans and expectations from the net proceeds of its public offering of its securities in the United States, its financial plans, its expected revenue models and generation, the potential of its technology and products, its strategy and its future growth. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties effecting the Company, reference is made to the Company's preliminary prospectus dated February 28, 2023, filed with the Securities and Exchange Commission ("SEC") as part of the Company's Registration Statement on Form F-1 (File No. 333-269496). Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. Free Writing Prospectus Disclaimer This presentation highlights basic information about us and the proposed offering. Because it is a summary, it does not contain all of the information that you should consider before investing. We have filed a registration statement on Form F-1 (File No. 333-269496) (the "registration statement") (including a preliminary prospectus) with the SEC for such offering to which this presentation relates. The registration statement has not yet become effective. Before you invest, you should read the prospectus in the registration statement (including the risk factors described therein) and other documents we have filed with the SEC for more complete information about us and such offering. A preliminary prospectus relating to the securities being offered have been filed with the SEC and are available on the SEC's website at http://www.sec.gov. A final prospectus relating to the offering will be filed with the SEC and, upon filing, may be obtained on the SEC's website. Alternatively, we or any underwriter participating in the offering will arrange to send you the prospectus if you contact ThinkEquity, Prospectus Department, 17 State Street, 41st Floor, New York, New York 10004, telephone: (877) 436-3673 or e-mail: [email protected]. This presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction. The offering will only be made by means of a prospectus included in the registration statement as and when the registration statement is declared effective by the SEC. Any decision to purchase our securities in the proposed offering should be made solely on the basis of the information contained in the prospectus. 2

View entire presentation